15.265 articles found

Clinical and biochemical features of Parkinson's disease : a cross-sectional and longitudinal analysis of the Oxford Discovery cohort dataset

Baig F.

· 2018-01-01

Exploring mechanisms of change in a pilot randomised trial of a distant delivery mindfulness intervention for people with Parkinson's disease

Coxon A.

· 2018-01-01

Effects of Transcranial Direct Current Stimulation Plus Physical Therapy on Gait in Patients With Parkinson Disease: A Randomized Controlled Trial.

Yotnuengnit P, Bhidayasiri R, Donkhan R, Chaluaysrimuang J, Piravej K.

Am J Phys Med Rehabil · 2018-01-01

DOI: 10.1097/phm.0000000000000783PMID: 28650857

Frontotemporal Lobar Degeneration (FTLD): Review and Update for Clinical Neurologists.

Hernandez I, Fernandez MV, Tarraga L, Boada M, Ruiz A.

Curr Alzheimer Res · 2018-01-01

DOI: 10.2174/1567205014666170725130819PMID: 28745227

Real-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders: a systematic review of randomized and nonrandomized studies.

Emsley R, Parellada E, Bioque M, Herrera B, Hernando T, García-Dorado M.

Int Clin Psychopharmacol · 2018-01-01

DOI: 10.1097/yic.0000000000000195PMID: 28817397

Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of Parkinson's Disease.

Requejo C, Ruiz-Ortega JA, Cepeda H, Sharma A, Sharma HS, Ozkizilcik A, Tian R, Moessler H, Ugedo L, Lafuente JV.

Mol Neurobiol · 2018-01-01

DOI: 10.1007/s12035-017-0741-xPMID: 28840482

Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's Disease.

Requejo C, Ruiz-Ortega JA, Bengoetxea H, Bulnes S, Ugedo L, Lafuente JV.

Mol Neurobiol · 2018-01-01

DOI: 10.1007/s12035-017-0733-xPMID: 28840516

AAgMarker 1.0: a resource of serological autoantigen biomarkers for clinical diagnosis and prognosis of various human diseases.

Pan J, Liu S, Zhu H, Qian J.

Nucleic Acids Res · 2018-01-01

DOI: 10.1093/nar/gkx770PMID: 28977551

Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.

Büchele F, Hackius M, Schreglmann SR, Omlor W, Werth E, Maric A, Imbach LL, Hägele-Link S, Waldvogel D, Baumann CR.

JAMA Neurol · 2018-01-01

DOI: 10.1001/jamaneurol.2017.3171PMID: 29114733

[Bilateral two-stage implantation for deep brain stimulation in the treatment of bilateral idiopathic Parkinson's disease: clinical outcomes].

Torres CV, Lopez-Manzanares L, Navas-Garcia M, Pastor J, Vega-Zelaya L, Garcia-Pallero MA, Sola RG.

Rev Neurol · 2018-01-01

PMID: 29251336

Comments on: 'Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial'.

Simões RM, Castro Caldas A, Ferreira JJ.

Eur J Neurol · 2018-01-01

DOI: 10.1111/ene.13475PMID: 29271586

[Amimia in Parkinson's disease. Significance and correlation with the clinical features].

Garcia-Ruiz PJ, Feliz-Feliz CE, Maycas-Cepeda T, Del Val-Fernandez J.

Rev Neurol · 2018-01-01

PMID: 29323400